Shares of BP p.l.c. BP rose sharply in pre-market trading.
The Wall Street Journal reported Sunday that Elliott Management has built a stake in BP and will push for transformational changes.
BP shares jumped 6% to $34.20 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Patriot National Bancorp, Inc. PNBK gained 70.6% to $2.44 in pre-market trading after falling over 3% on Friday.
- Starbox Group Holdings Ltd. STBX rose 51% to $0.5020 in pre-market trading after falling around 4% on Friday.
- MGO Global, Inc. MGOL gained 43.3% to $0.5953 in pre-market trading after jumping 124% on Friday.
- Cyngn Inc. CYN gained 32.1% to $0.0795 in pre-market trading after dipping over 28% on Friday.
- Yoshiharu Global Co. YOSH shares jumped 24.4% to $8.20 in pre-market trading after jumping 34% on Friday.
- Microbot Medical Inc. MBOT gained 20% to $3.06 after surging around 18% on Friday.
- Solid Biosciences Inc. SLDB shares climbed 19.1% to $3.43 in pre-market trading after dipping 8% on Friday.
- Satellogic Inc. SATL gained 13.6% to $4.19 in pre-market trading after climbing 10% on Friday.
- Century Aluminum Company CENX gained 9.4% to $20.44 in pre-market.
Losers
- Fennec Pharmaceuticals Inc. FENC shares fell 54.8% to $3.00 in pre-market trading.
- Pliant Therapeutics, Inc. PLRX dipped 54.5% to $3.54 in pre-market trading after the company issued an update on BEACON-IPF, a Phase 2b/3 trial in patients with idiopathic pulmonary fibrosis.
- Mynaric AG MYNA fell 32.7% to $0.2550 in today's pre-market trading after gaining over 11% on Friday.
- PS International Group Ltd. PSIG shares fell 25.4% to $0.4701 in pre-market trading after gaining 5% on Friday.
- Semtech Corporation SMTC shares tumbled 25.2% to $40.75 in pre-market trading. Semtech shares fell around 10% on Friday after Baird cut its price target on the stock from $80 to $60.
- Oriental Rise Holdings Limited ORIS declined 20.2% to $0.91 in pre-market trading after falling more than 5% on Friday.
- Replimune Group, Inc. REPL fell 19.6% to $11.21 in pre-market trading. Replimune announced inducement grants under Nasdaq Listing Rule 5635(c)(4).
- Maze Therapeutics, Inc. MAZE fell 9.5% to $12.11 in pre-market trading. Maze Therapeutics shares gained around 3% on Friday after the company announced that the first patient has been dosed in the company’s Phase 2 clinical trial, the HORIZON Study, of MZE829 in patients with APOL1 kidney disease.
- Dogness (International) Corporation DOGZ fell 6.6% to $33.00 in pre-market trading.
- The Manitowoc Company, Inc. MTW shares dipped 6.4% to $9.12 in pre-market trading.
Now Read This:
BPBP PLC
$33.980.64%
Edge Rankings
Momentum41.62
Growth97.58
Quality-
Value-
Price Trend
Short
Medium
Long
CENXCentury Aluminum Co
$20.04-2.03%
CYNCyngn Inc
$4.32-3.79%
DOGZDogness (International) Corp
$29.20-0.17%
FENCFennec Pharmaceuticals Inc
$6.462.22%
MAZEMaze Therapeutics Inc
$11.994.35%
MBOTMicrobot Medical Inc
$1.63-1.81%
MTWManitowoc Co Inc
$9.54-0.21%
ORISOriental Rise Holdings Ltd
$1.15-0.01%
PLRXPliant Therapeutics Inc
$1.66-2.35%
PNBKPatriot National Bancorp Inc
$1.01-%
PSIGPS International Group Ltd
$0.48255.12%
REPLReplimune Group Inc
$11.46-2.72%
SATLSatellogic Inc
$3.89-4.19%
SLDBSolid Biosciences Inc
$5.09-5.04%
SMTCSemtech Corp
$38.82-1.55%
STBXStarbox Group Holdings Ltd
$0.225010.8%
YOSHYoshiharu Global Co
$19.00-6.77%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in